Intestinal Fatty Acid–Binding Protein as a Marker of Necrotizing Enterocolitis Incidence and Severity: A Scoping Review

Introduction

Necrotizing enterocolitis (NEC) is a severe inflammatory disease of the gastrointestinal tract and one of the most common life-threatening emergencies affecting newborns. Intestinal fatty acid–binding protein (I-FABP) has been used as a possible marker of intestinal damage in NEC. We aimed to carry out a scoping review of all publications that explore the role of I-FABP in NEC to inspire new research into the potential utility of I-FABP as a marker of NEC.

Methods

We searched for relevant publications using the keywords “necrotizing enterocolitis,” “intestinal fatty acid binding protein,” “NEC,” and “I-FABP” in the National Library of Medicine (PubMed/MEDLINE), Embase, SCOPUS, and Web of Science. Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews was used for reporting findings.

Results

We identified 61 relevant articles, which we divided into clinical (n = 47) and experimental (n = 14) groups.

Conclusions

I-FABP is a promising marker of NEC, especially for NEC stage 2 and 3. Urinary I-FABP follows the same patterns as serum and plasma I-FABP. The definitive roles of I-FABP in early diagnosis of NEC, differential diagnosis in breast feeding, alimentary intolerance, and screening of surgical NEC need clarification and remain a challenge to investigators.